Akèy › Dyabèt Tip 2 › New Mexico
Etid klinik pou Dyabèt Tip 2 nan New Mexico
12 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan New Mexico.
Vil nan New Mexico
Tèks ofisyèl etid la (Anglè)
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Albuquerque Clinical Trials Inc., Albuquerque
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07817251EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- New Mexico Clinical Research and Osteoporosis Center, Inc., Albuquerque
- IMA Clinical Research Albuquerque, Albuquerque
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Albuquerque Clinical Trials, Albuquerque
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07754461A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Albuquerque Clinical Trials, Inc., Albuquerque
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07595549A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Albuquerque Clinical Trials, Inc., Albuquerque
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- Albuquerque Clinical Trials Inc, Albuquerque
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 15, 2026 · NCT07340320A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Albuquerque
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07662213Ketogenic Diet and Diabetes Demonstration Project
- University of New Mexico, Albuquerque
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06115265A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, Albuquerque
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT07662135A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Albuquerque
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT07662109A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- University of New Mexico Hospital, Albuquerque
Ap rekriteFaz 3
Laj 10 a 17 · Tout sèks · Mizajou Aug 7, 2026 · NCT06739122DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
- Colorado Navajo Nation, Shiprock
Ap rekriteEtid obsèvasyon
Laj 8 a 15 · Tout sèks · Mizajou May 7, 2026 · NCT06525259Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.